
CAS 38127-17-2
:(5S,6S)-6-AMINO-5-HYDROXYCYCLOHEXA-1,3-DIENECARBOXYLIC ACID
Description:
(5S,6S)-6-Amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid, with the CAS number 38127-17-2, is an organic compound characterized by its unique bicyclic structure that includes both amino and hydroxy functional groups. This compound is a derivative of cyclohexadiene, featuring a carboxylic acid group that contributes to its acidity and reactivity. The presence of the amino group suggests potential for forming hydrogen bonds, which can influence its solubility and interaction with biological systems. The stereochemistry indicated by the (5S,6S) configuration implies specific spatial arrangements of its substituents, which can affect its biological activity and reactivity. This compound may be of interest in pharmaceutical research due to its structural features, which could mimic or interact with biological molecules. Its properties, such as melting point, solubility, and stability, would be influenced by the functional groups present and the overall molecular conformation. Further studies would be necessary to explore its potential applications and mechanisms of action in various chemical and biological contexts.
Formula:C7H9NO3
Synonyms:- (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-diene-1-carboxylic acid
- (5S,6S)-6-AMINO-5-HYDROXYCYCLOHEXA-1,3-DIENECARBOXYLIC ACID
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid
CAS:(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acidColor and Shape:White SolidMolecular weight:155.15g/mol(5S,6S)-6-Amino-5-hydroxycyclohexa- 1,3-dienecarboxylic acid
CAS:<p>(5S,6S)-6-Amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid is a reactive bicyclic heterocycle that is used in the treatment of some types of cancer. It is an inhibitor of DNA polymerase and transcriptional regulation. The m2 phenotype, which is characterized by a high expression level of cyclin E and low levels of p21 and p27 proteins, is associated with the use of (5S,6S)-6-Amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid. This drug has been shown to be effective in the treatment of breast cancer cells that have the m2 phenotype.</p>Formula:C7H9NO3Purity:Min. 95%Molecular weight:155.15 g/mol

